Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:InChIKey
|
| gptkbp:brand |
gptkb:Tylenol
gptkb:Panadol gptkb:Paracetamol |
| gptkbp:CASNumber |
103-90-2
|
| gptkbp:chemicalFormula |
C8H9NO2
|
| gptkbp:correspondsTo |
gptkb:paracetamol
|
| gptkbp:discoveredIn |
1877
|
| gptkbp:excretion |
urine
|
| gptkbp:hasSMILES |
CC(=O)NC1=CC=C(O)C=C1
|
| gptkbp:hasTherapeuticUse |
gptkb:analgesic
gptkb:antipyretic |
| gptkbp:InChIKeyFor |
acetaminophen
|
| gptkbp:isApprovedDrug |
true
|
| gptkbp:isATCCode |
N02BE01
|
| gptkbp:isDrugBankID |
DB00316
|
| gptkbp:IUPACName |
N-(4-hydroxyphenyl)acetamide
|
| gptkbp:legalStatus |
gptkb:OTC
|
| gptkbp:meltingPoint |
168 °C
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
151.16 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL112
1983 |
| gptkbp:routeOfAdministration |
oral
intravenous rectal |
| gptkbp:sideEffect |
liver damage (in overdose)
|
| gptkbp:solubility |
14 mg/mL
|
| gptkbp:UNII |
362O9ITL9D
|
| gptkbp:bfsParent |
gptkb:triphenylphosphine
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
RZVAJINKPMORJF-UHFFFAOYSA-N
|